Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00381550
Brief Title: 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

First Submitted : September 26, 2006
First Submitted that Met QC Criteria : September 26, 2006
First Posted : September 28, 2006 (Estimate)

Results First Submitted : April 23, 2014
Results First Submitted that Met QC Criteria : April 23, 2014
Results First Posted : May 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : December 16, 2014
Last Update Posted : January 6, 2015 (Estimate)